MS drug from Novartis investigated after at least 11 deaths

January 20, 2012 at 4:29 am in Grand Forks Herald

The deaths raise concerns Gilenya could trigger heart problems after patients take their first dose, according to a statement issued today by the European Medicines Agency. The agency, which is now investigating the drug, said it isn’t clear if it caused the deaths. Continue Reading